Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

被引:669
|
作者
Moslehi, Javid J. [1 ,2 ,3 ]
Salem, Joe-Elie [1 ,3 ,4 ]
Sosman, Jeffrey A. [5 ,6 ]
Lebrun-Vignes, Benedicte [4 ]
Johnson, Douglas B. [2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Div Oncol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Med, Cardiooncol Program, Nashville, TN 37232 USA
[4] UPMC Univ Paris 06, Pitie Salpetriere Hosp, AP HP,UMR ICAN 1166,Sorbonne Univ,Fac Med,ICAN, Dept Pharmacol,CIC 1421,Pharmacovigilance Unit,IN, Paris, France
[5] Northwestern Univ, Dept Med, Chicago, IL 60611 USA
[6] Northwestern Univ, Robert H Lurie Canc Ctr, Chicago, IL 60611 USA
来源
LANCET | 2018年 / 391卷 / 10124期
关键词
CARDIOTOXICITY;
D O I
10.1016/S0140-6736(18)30533-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:933 / 933
页数:1
相关论文
共 50 条
  • [21] Advances in research on molecular markers in immune checkpoint inhibitor-associated myocarditis
    Shao, Jun
    Liu, Chuanbin
    Wang, Jing
    CANCER INNOVATION, 2023, 2 (06): : 439 - 447
  • [22] Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor-associated myocarditis
    Cau, Riccardo
    Solinas, Cinzia
    De Silva, Pushpamali
    Lambertini, Matteo
    Agostinetto, Elisa
    Scartozzi, Mario
    Montisci, Roberta
    Pontone, Gianluca
    Porcu, Michele
    Saba, Luca
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (11) : 1860 - 1873
  • [23] Immune checkpoint inhibitor-associated myocarditis Case reports and a review of the literature
    Osinga, T. E.
    Oosting, S. F.
    van der Meer, P.
    de Boer, R. A.
    Kuenen, B. C.
    Rutgers, A.
    Bergmann, L.
    Munnink, T. H. Oude
    Jalving, M.
    van Kruchten, M.
    NETHERLANDS HEART JOURNAL, 2022, 30 (06) : 295 - 301
  • [24] Immune checkpoint inhibitor-associated myocarditis: New insight in an underestimated issue
    Evers, G.
    Chatzantonis, G.
    Mohr, M.
    Schulze, A.
    Meier, C.
    Bietenbeck, M.
    Florian, A.
    Klingel, K.
    Yilmaz, A.
    Bleckmann, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 196 - 196
  • [25] Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated Myocarditis
    Drobni, Zsofia D.
    Zafar, Amna
    Zubiri, Leyre
    Zlotoff, Daniel A.
    Alvi, Raza M.
    Lee, Charlotte
    Hartmann, Sarah
    Gilman, Hannah K.
    Villani, Alexandra-Chloe
    Nohria, Anju
    Groarke, John D.
    Sullivan, Ryan J.
    Reynolds, Kerry L.
    Zhang, Lili
    Neilan, Tomas G.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (23):
  • [26] The role of immune mechanism in Immune Checkpoint Inhibitor-Associated Myocarditis: seeking key genes
    Zhang, Junyi
    Qu, Shenglin
    Zhou, Yafeng
    CIRCULATION, 2024, 150
  • [27] Increased reporting of fatal hepatitis associated with immune checkpoint inhibitors
    Vozy, Aurore
    De Martin, Eleonora
    Johnson, Douglas B.
    Lebrun-Vignes, Benedicte
    Moslehi, Javid J.
    Salem, Joe-Elie
    EUROPEAN JOURNAL OF CANCER, 2019, 123 : 112 - 115
  • [28] Identification of shared mechanisms and targets between immune checkpoint inhibitor-associated myocarditis and autoimmune myocarditis
    Yang, Kai
    Zhang, Min
    Li, Dong
    Yu, Yuandong
    Cao, Fengjun
    Wan, Guoxing
    EUROPEAN JOURNAL OF INFLAMMATION, 2024, 22
  • [29] Immune Checkpoint Inhibitor-Associated Myocarditis: Learning from mice and humans.
    Moslehi, Javid
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12) : 3 - 3
  • [30] Immune checkpoint inhibitor-associated myasthenia gravis, myositis, and myocarditis overlap syndrome
    Lipe, Demis N.
    Galvis-Carvajal, Elkin
    Rajha, Eva
    Wechsler, Adriana H.
    Gaeta, Susan
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 46 : 51 - 55